ROVI announces the agreement to market Hirobriz Breezhaler y Ulunar Breezhaler en España


No votes yet
 
Related
Today, Laboratorios Farmacéuticos ROVI, S.A. (“ROVI”) has signed a Protocol of Intentions with the Regional Government of Castilla-La...
3 min
08/07/2026
​Total revenue in the first quarter of 2026 amounted to 154.7 million euros, in line with the same period of the previous year....
4 min
06/05/2026
In compliance with the disclosure obligations set forth in Article 227 of Law 6/2023, of 17 March, on Securities Markets and Investment...
2 min
01/04/2026